Global Veterinary Vaccine Market Growth 2023-2029

The global Veterinary Vaccine market size is projected to grow from US$ 10570 million in 2022 to US$ 17200 million in 2029; it is expected to grow at a CAGR of 7.2% from 2023 to 2029.

Global veterinary vaccine key players include Merck, Zoetis, Boehringer Ingelheim, Ceva, and others. The top three producers together account for more than 60% of the market share, with Merck being the largest producer with approximately 25%. Global origins are mainly in North America, Europe, China, India, Latin America, South America, South Korea, Japan, Turkey, Middle East, Southeast Asia, etc. In terms of their products, live attenuated vaccines have the largest market share with a 50% share, followed by inactivated vaccines. In terms of its application, farm animals are the number one target, with a 70% market share.

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

LPI (LP Information)' newest research report, the “Veterinary Vaccine Industry Forecast” looks at past sales and reviews total world Veterinary Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary Vaccine sales for 2023 through 2029. With Veterinary Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Veterinary Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Vaccine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Live Attenuated Vaccines
    Inactivated Vaccines
    Other

Segmentation by application
    Farm Animal
    Companion Animal

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Merck
    Zoetis
    Boehringer Ingelheim
    Ceva
    CAHIC
    HVRI
    Ringpu Biology
    Yebio
    DHN
    WINSUN
    Elanco
    Virbac
    Jinyu Bio-Technology
    ChengDu Tecbond
    CAVAC
    Kyoto Biken Laboratories
    FATRO
    Vaksindo
    Bio-Labs
    Avimex Animal Health
    MEVAC
    Biovac
    Atafen
    Dyntec
    RVSRI
    Medion

Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Vaccine market?
What factors are driving Veterinary Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Vaccine market opportunities vary by end market size?
How does Veterinary Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

List of Tables
    Table 1. Veterinary Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Veterinary Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of Live Attenuated Vaccines
    Table 4. Major Players of Inactivated Vaccines
    Table 5. Major Players of Other
    Table 6. Global Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
    Table 7. Global Veterinary Vaccine Sales Market Share by Type (2018-2023)
    Table 8. Global Veterinary Vaccine Revenue by Type (2018-2023) & ($ million)
    Table 9. Global Veterinary Vaccine Revenue Market Share by Type (2018-2023)
    Table 10. Global Veterinary Vaccine Sale Price by Type (2018-2023) & (USD/K Doses)
    Table 11. Global Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
    Table 12. Global Veterinary Vaccine Sales Market Share by Application (2018-2023)
    Table 13. Global Veterinary Vaccine Revenue by Application (2018-2023)
    Table 14. Global Veterinary Vaccine Revenue Market Share by Application (2018-2023)
    Table 15. Global Veterinary Vaccine Sale Price by Application (2018-2023) & (USD/K Doses)
    Table 16. Global Veterinary Vaccine Sales by Company (2018-2023) & (M Doses)
    Table 17. Global Veterinary Vaccine Sales Market Share by Company (2018-2023)
    Table 18. Global Veterinary Vaccine Revenue by Company (2018-2023) ($ Millions)
    Table 19. Global Veterinary Vaccine Revenue Market Share by Company (2018-2023)
    Table 20. Global Veterinary Vaccine Sale Price by Company (2018-2023) & (USD/K Doses)
    Table 21. Key Manufacturers Veterinary Vaccine Producing Area Distribution and Sales Area
    Table 22. Players Veterinary Vaccine Products Offered
    Table 23. Veterinary Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global Veterinary Vaccine Sales by Geographic Region (2018-2023) & (M Doses)
    Table 27. Global Veterinary Vaccine Sales Market Share Geographic Region (2018-2023)
    Table 28. Global Veterinary Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 29. Global Veterinary Vaccine Revenue Market Share by Geographic Region (2018-2023)
    Table 30. Global Veterinary Vaccine Sales by Country/Region (2018-2023) & (M Doses)
    Table 31. Global Veterinary Vaccine Sales Market Share by Country/Region (2018-2023)
    Table 32. Global Veterinary Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
    Table 33. Global Veterinary Vaccine Revenue Market Share by Country/Region (2018-2023)
    Table 34. Americas Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
    Table 35. Americas Veterinary Vaccine Sales Market Share by Country (2018-2023)
    Table 36. Americas Veterinary Vaccine Revenue by Country (2018-2023) & ($ Millions)
    Table 37. Americas Veterinary Vaccine Revenue Market Share by Country (2018-2023)
    Table 38. Americas Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
    Table 39. Americas Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
    Table 40. APAC Veterinary Vaccine Sales by Region (2018-2023) & (M Doses)
    Table 41. APAC Veterinary Vaccine Sales Market Share by Region (2018-2023)
    Table 42. APAC Veterinary Vaccine Revenue by Region (2018-2023) & ($ Millions)
    Table 43. APAC Veterinary Vaccine Revenue Market Share by Region (2018-2023)
    Table 44. APAC Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
    Table 45. APAC Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
    Table 46. Europe Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
    Table 47. Europe Veterinary Vaccine Sales Market Share by Country (2018-2023)
    Table 48. Europe Veterinary Vaccine Revenue by Country (2018-2023) & ($ Millions)
    Table 49. Europe Veterinary Vaccine Revenue Market Share by Country (2018-2023)
    Table 50. Europe Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
    Table 51. Europe Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
    Table 52. Middle East & Africa Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
    Table 53. Middle East & Africa Veterinary Vaccine Sales Market Share by Country (2018-2023)
    Table 54. Middle East & Africa Veterinary Vaccine Revenue by Country (2018-2023) & ($ Millions)
    Table 55. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country (2018-2023)
    Table 56. Middle East & Africa Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
    Table 57. Middle East & Africa Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
    Table 58. Key Market Drivers & Growth Opportunities of Veterinary Vaccine
    Table 59. Key Market Challenges & Risks of Veterinary Vaccine
    Table 60. Key Industry Trends of Veterinary Vaccine
    Table 61. Veterinary Vaccine Raw Material
    Table 62. Key Suppliers of Raw Materials
    Table 63. Veterinary Vaccine Distributors List
    Table 64. Veterinary Vaccine Customer List
    Table 65. Global Veterinary Vaccine Sales Forecast by Region (2024-2029) & (M Doses)
    Table 66. Global Veterinary Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 67. Americas Veterinary Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
    Table 68. Americas Veterinary Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 69. APAC Veterinary Vaccine Sales Forecast by Region (2024-2029) & (M Doses)
    Table 70. APAC Veterinary Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 71. Europe Veterinary Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
    Table 72. Europe Veterinary Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 73. Middle East & Africa Veterinary Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
    Table 74. Middle East & Africa Veterinary Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 75. Global Veterinary Vaccine Sales Forecast by Type (2024-2029) & (M Doses)
    Table 76. Global Veterinary Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 77. Global Veterinary Vaccine Sales Forecast by Application (2024-2029) & (M Doses)
    Table 78. Global Veterinary Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 79. Merck Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 80. Merck Veterinary Vaccine Product Portfolios and Specifications
    Table 81. Merck Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 82. Merck Main Business
    Table 83. Merck Latest Developments
    Table 84. Zoetis Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 85. Zoetis Veterinary Vaccine Product Portfolios and Specifications
    Table 86. Zoetis Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 87. Zoetis Main Business
    Table 88. Zoetis Latest Developments
    Table 89. Boehringer Ingelheim Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 90. Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
    Table 91. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 92. Boehringer Ingelheim Main Business
    Table 93. Boehringer Ingelheim Latest Developments
    Table 94. Ceva Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 95. Ceva Veterinary Vaccine Product Portfolios and Specifications
    Table 96. Ceva Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 97. Ceva Main Business
    Table 98. Ceva Latest Developments
    Table 99. CAHIC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 100. CAHIC Veterinary Vaccine Product Portfolios and Specifications
    Table 101. CAHIC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 102. CAHIC Main Business
    Table 103. CAHIC Latest Developments
    Table 104. HVRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 105. HVRI Veterinary Vaccine Product Portfolios and Specifications
    Table 106. HVRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 107. HVRI Main Business
    Table 108. HVRI Latest Developments
    Table 109. Ringpu Biology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 110. Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
    Table 111. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 112. Ringpu Biology Main Business
    Table 113. Ringpu Biology Latest Developments
    Table 114. Yebio Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 115. Yebio Veterinary Vaccine Product Portfolios and Specifications
    Table 116. Yebio Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 117. Yebio Main Business
    Table 118. Yebio Latest Developments
    Table 119. DHN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 120. DHN Veterinary Vaccine Product Portfolios and Specifications
    Table 121. DHN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 122. DHN Main Business
    Table 123. DHN Latest Developments
    Table 124. WINSUN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 125. WINSUN Veterinary Vaccine Product Portfolios and Specifications
    Table 126. WINSUN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 127. WINSUN Main Business
    Table 128. WINSUN Latest Developments
    Table 129. Elanco Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 130. Elanco Veterinary Vaccine Product Portfolios and Specifications
    Table 131. Elanco Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 132. Elanco Main Business
    Table 133. Elanco Latest Developments
    Table 134. Virbac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 135. Virbac Veterinary Vaccine Product Portfolios and Specifications
    Table 136. Virbac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 137. Virbac Main Business
    Table 138. Virbac Latest Developments
    Table 139. Jinyu Bio-Technology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 140. Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
    Table 141. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 142. Jinyu Bio-Technology Main Business
    Table 143. Jinyu Bio-Technology Latest Developments
    Table 144. ChengDu Tecbond Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 145. ChengDu Tecbond Veterinary Vaccine Product Portfolios and Specifications
    Table 146. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 147. ChengDu Tecbond Main Business
    Table 148. ChengDu Tecbond Latest Developments
    Table 149. CAVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 150. CAVAC Veterinary Vaccine Product Portfolios and Specifications
    Table 151. CAVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 152. CAVAC Main Business
    Table 153. CAVAC Latest Developments
    Table 154. Kyoto Biken Laboratories Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 155. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
    Table 156. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 157. Kyoto Biken Laboratories Main Business
    Table 158. Kyoto Biken Laboratories Latest Developments
    Table 159. FATRO Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 160. FATRO Veterinary Vaccine Product Portfolios and Specifications
    Table 161. FATRO Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 162. FATRO Main Business
    Table 163. FATRO Latest Developments
    Table 164. Vaksindo Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 165. Vaksindo Veterinary Vaccine Product Portfolios and Specifications
    Table 166. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 167. Vaksindo Main Business
    Table 168. Vaksindo Latest Developments
    Table 169. Bio-Labs Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 170. Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
    Table 171. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 172. Bio-Labs Main Business
    Table 173. Bio-Labs Latest Developments
    Table 174. Avimex Animal Health Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 175. Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
    Table 176. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 177. Avimex Animal Health Main Business
    Table 178. Avimex Animal Health Latest Developments
    Table 179. MEVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 180. MEVAC Veterinary Vaccine Product Portfolios and Specifications
    Table 181. MEVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 182. MEVAC Main Business
    Table 183. MEVAC Latest Developments
    Table 184. Biovac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 185. Biovac Veterinary Vaccine Product Portfolios and Specifications
    Table 186. Biovac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 187. Biovac Main Business
    Table 188. Biovac Latest Developments
    Table 189. Atafen Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 190. Atafen Veterinary Vaccine Product Portfolios and Specifications
    Table 191. Atafen Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 192. Atafen Main Business
    Table 193. Atafen Latest Developments
    Table 194. Dyntec Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 195. Dyntec Veterinary Vaccine Product Portfolios and Specifications
    Table 196. Dyntec Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 197. Dyntec Main Business
    Table 198. Dyntec Latest Developments
    Table 199. RVSRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 200. RVSRI Veterinary Vaccine Product Portfolios and Specifications
    Table 201. RVSRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 202. RVSRI Main Business
    Table 203. RVSRI Latest Developments
    Table 204. Medion Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 205. Medion Veterinary Vaccine Product Portfolios and Specifications
    Table 206. Medion Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 207. Medion Main Business
    Table 208. Medion Latest Developments
List of Figures
    Figure 1. Picture of Veterinary Vaccine
    Figure 2. Veterinary Vaccine Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Veterinary Vaccine Sales Growth Rate 2018-2029 (M Doses)
    Figure 7. Global Veterinary Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Veterinary Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of Live Attenuated Vaccines
    Figure 10. Product Picture of Inactivated Vaccines
    Figure 11. Product Picture of Other
    Figure 12. Global Veterinary Vaccine Sales Market Share by Type in 2022
    Figure 13. Global Veterinary Vaccine Revenue Market Share by Type (2018-2023)
    Figure 14. Veterinary Vaccine Consumed in Farm Animal
    Figure 15. Global Veterinary Vaccine Market: Farm Animal (2018-2023) & (M Doses)
    Figure 16. Veterinary Vaccine Consumed in Companion Animal
    Figure 17. Global Veterinary Vaccine Market: Companion Animal (2018-2023) & (M Doses)
    Figure 18. Global Veterinary Vaccine Sales Market Share by Application (2022)
    Figure 19. Global Veterinary Vaccine Revenue Market Share by Application in 2022
    Figure 20. Veterinary Vaccine Sales Market by Company in 2022 (M Doses)
    Figure 21. Global Veterinary Vaccine Sales Market Share by Company in 2022
    Figure 22. Veterinary Vaccine Revenue Market by Company in 2022 ($ Million)
    Figure 23. Global Veterinary Vaccine Revenue Market Share by Company in 2022
    Figure 24. Global Veterinary Vaccine Sales Market Share by Geographic Region (2018-2023)
    Figure 25. Global Veterinary Vaccine Revenue Market Share by Geographic Region in 2022
    Figure 26. Americas Veterinary Vaccine Sales 2018-2023 (M Doses)
    Figure 27. Americas Veterinary Vaccine Revenue 2018-2023 ($ Millions)
    Figure 28. APAC Veterinary Vaccine Sales 2018-2023 (M Doses)
    Figure 29. APAC Veterinary Vaccine Revenue 2018-2023 ($ Millions)
    Figure 30. Europe Veterinary Vaccine Sales 2018-2023 (M Doses)
    Figure 31. Europe Veterinary Vaccine Revenue 2018-2023 ($ Millions)
    Figure 32. Middle East & Africa Veterinary Vaccine Sales 2018-2023 (M Doses)
    Figure 33. Middle East & Africa Veterinary Vaccine Revenue 2018-2023 ($ Millions)
    Figure 34. Americas Veterinary Vaccine Sales Market Share by Country in 2022
    Figure 35. Americas Veterinary Vaccine Revenue Market Share by Country in 2022
    Figure 36. Americas Veterinary Vaccine Sales Market Share by Type (2018-2023)
    Figure 37. Americas Veterinary Vaccine Sales Market Share by Application (2018-2023)
    Figure 38. United States Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 39. Canada Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 40. Mexico Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 41. Brazil Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 42. APAC Veterinary Vaccine Sales Market Share by Region in 2022
    Figure 43. APAC Veterinary Vaccine Revenue Market Share by Regions in 2022
    Figure 44. APAC Veterinary Vaccine Sales Market Share by Type (2018-2023)
    Figure 45. APAC Veterinary Vaccine Sales Market Share by Application (2018-2023)
    Figure 46. China Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 47. Japan Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 48. South Korea Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 49. Southeast Asia Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 50. India Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 51. Australia Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 52. China Taiwan Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 53. Europe Veterinary Vaccine Sales Market Share by Country in 2022
    Figure 54. Europe Veterinary Vaccine Revenue Market Share by Country in 2022
    Figure 55. Europe Veterinary Vaccine Sales Market Share by Type (2018-2023)
    Figure 56. Europe Veterinary Vaccine Sales Market Share by Application (2018-2023)
    Figure 57. Germany Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 58. France Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 59. UK Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 60. Italy Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 61. Russia Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 62. Middle East & Africa Veterinary Vaccine Sales Market Share by Country in 2022
    Figure 63. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country in 2022
    Figure 64. Middle East & Africa Veterinary Vaccine Sales Market Share by Type (2018-2023)
    Figure 65. Middle East & Africa Veterinary Vaccine Sales Market Share by Application (2018-2023)
    Figure 66. Egypt Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 67. South Africa Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 68. Israel Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 69. Turkey Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 70. GCC Country Veterinary Vaccine Revenue Growth 2018-2023 ($ Millions)
    Figure 71. Manufacturing Cost Structure Analysis of Veterinary Vaccine in 2022
    Figure 72. Manufacturing Process Analysis of Veterinary Vaccine
    Figure 73. Industry Chain Structure of Veterinary Vaccine
    Figure 74. Channels of Distribution
    Figure 75. Global Veterinary Vaccine Sales Market Forecast by Region (2024-2029)
    Figure 76. Global Veterinary Vaccine Revenue Market Share Forecast by Region (2024-2029)
    Figure 77. Global Veterinary Vaccine Sales Market Share Forecast by Type (2024-2029)
    Figure 78. Global Veterinary Vaccine Revenue Market Share Forecast by Type (2024-2029)
    Figure 79. Global Veterinary Vaccine Sales Market Share Forecast by Application (2024-2029)
    Figure 80. Global Veterinary Vaccine Revenue Market Share Forecast by Application (2024-2029)

Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
RVSRI
Medion

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape